Analysis of European at-risk versus general population individuals combined PNPLA3-TM6SF2-GCKR-MBOAT7 variants in a hepatic fat polygenic risk score adjusted for HSD17B13 to predict HCC even in the absence of severe fibrosis (185). This evidence concerns the gene PNPLA3 and hepatocellular carcinoma.